Related Experiment Video
Updated: May 23, 2026
09:21
Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons
Published on: July 7, 2023
Molecular insights into Parkinson's disease
Jean-Christophe Rochet1, Bruce A Hay, Ming Guo
1Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana, USA.
Progress in Molecular Biology and Translational Science
|April 10, 2012
Summary
Parkinson's disease research reveals key gene roles. Understanding alpha-synuclein, PINK1/parkin, and DJ-1 sheds light on neurodegeneration and mitochondrial dysfunction in Parkinson's disease.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Parkinson's disease (PD) is the second most common neurodegenerative disorder.
- Mutations in SNCA, PINK1, parkin, and DJ-1 are linked to familial PD.
- Understanding these gene products offers insights into sporadic PD.
Purpose of the Study:
- To review recent advances in understanding four PD-related gene products.
- To explore the role of alpha-synuclein in Parkinson's disease.
- To summarize developments in mitochondrial dysfunction, focusing on the PINK1/parkin pathway and DJ-1.
Main Methods:
- Literature review of recent advances in PD-related gene research.
- Analysis of structural and functional properties of gene products.
- Synthesis of information on alpha-synuclein, PINK1, parkin, and DJ-1.
Main Results:
- New insights into the role of alpha-synuclein in PD.
- Latest developments in mitochondrial dysfunction, including the PINK1/parkin pathway's role in mitochondrial dynamics and mitophagy.
- Discussion on the role of DJ-1.
Conclusions:
- Converging pathways identified among PD-related genes.
- Future research directions highlighted for Parkinson's disease.
- Enhanced understanding of the molecular basis of familial and sporadic Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...